[Carotid barostimulation in the treatment of resistant hypertension].
Fiche publication
Date publication
avril 2016
Journal
Nephrologie & therapeutique
Lien Pubmed
Résumé
The autonomic nervous system plays a pivotal role in the development of hypertension and organ damage complicating hypertension. The US company CVRx developed medical devices (first generation Rheos™ and second generation Neo™) aimed to electronically activate baroreceptors, which signal the brain to orchestrate a multisystemic response to address chronic diseases such as hypertension and heart failure. This review presents available clinical trial data on carotid barostimulation in the treatment of resistant hypertension.
Mots clés
Carotid Arteries, Clinical Trials as Topic, Drug Resistance, Electric Stimulation Therapy, instrumentation, Equipment Design, Heart Failure, diagnosis, Humans, Hypertension, diagnosis, Pressoreceptors, Severity of Illness Index, Treatment Outcome
Référence
Nephrol. Ther.. 2016 Apr;12 Suppl 1:S133-4